Thomas Neylon is currently the VP of Tax at Genmab, having previously served as SVP Tax at Endo Pharmaceuticals from 2020 to 2025. Before that, Thomas held the position of VP, International Tax at Novartis from 2016 to 2020 and VP Tax at Syngenta from 1997 to 2016. Thomas earned a Bachelor of Science in Accounting and Finance from the University of Delaware's Lerner College of Business and Economics and a Doctor of Law in Tax Law from Widener University School of Law.
This person is not in any teams
This person is not in any offices